Archive: September 2019

 Subscribe to September 2019

Vestager’s Digital Antitrust Blueprint

September 24, 2019

Posted in Ethics
Effects of Commissioner Vestager’s unprecedented nomination to a second term as Competition Commissioner and dual mandate as Executive Vice-President for a Europe fit for the Digital Age (Digital Commissioner).

AI and drug discovery, Part 3: Protecting the value of data in collaborations

September 23, 2019

In Part 3, we highlight some of the legal issues surrounding the use of AI/ML in collaborative drug discovery and some solutions for addressing these issues.

AI and drug discovery, Part 2: In-depth look at the Mellody Project

September 16, 2019

Part 2 looks at an historic cross-competitor collaboration in the EU that is also leveraging blockchain technology to share large amounts of data to improve predictive models in drug discovery.

Singapore court’s cryptocurrency decision: Implications for cryptocurrency trading, smart contracts and AI

September 16, 2019

Singaporean court’s decision in relation to cryptocurrency trading has implications for cryptocurrency trading mistakes, smart contracts, artificial intelligence and whether cryptocurrency is property

AI and drug discovery, Part 1: Collaborations between pharma and AI

September 09, 2019

In Part 1 of this update for 2019, we outline some of the key areas of advancements and discuss some of the recent partnerships between pharma companies and AI companies.